Gehrke, M.; Diedrichs-Möhring, M.; Bogedein, J.; Büning, H.; Michalakis, S.; Wildner, G.
Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy. Cells 2022, 11, 1881.
https://doi.org/10.3390/cells11121881
AMA Style
Gehrke M, Diedrichs-Möhring M, Bogedein J, Büning H, Michalakis S, Wildner G.
Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy. Cells. 2022; 11(12):1881.
https://doi.org/10.3390/cells11121881
Chicago/Turabian Style
Gehrke, Miranda, Maria Diedrichs-Möhring, Jacqueline Bogedein, Hildegard Büning, Stylianos Michalakis, and Gerhild Wildner.
2022. "Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy" Cells 11, no. 12: 1881.
https://doi.org/10.3390/cells11121881
APA Style
Gehrke, M., Diedrichs-Möhring, M., Bogedein, J., Büning, H., Michalakis, S., & Wildner, G.
(2022). Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy. Cells, 11(12), 1881.
https://doi.org/10.3390/cells11121881